NCT00572403View on ClinicalTrials.gov

Risk Factors Contributing to the Development of Microalbuminuria

CompletedOBSERVATIONAL
Enrollment

10

Participants

Timeline

Start Date

December 31, 2007

Study Completion Date

April 30, 2008

Conditions
Microalbuminuria
Trial Locations (1)

M4N3M5

Sunnybrook Health Sciences Centre, Toronto

All Listed Sponsors
collaborator

Merck Frosst Canada Ltd.

INDUSTRY

lead

Sunnybrook Health Sciences Centre

OTHER

NCT00572403 - Risk Factors Contributing to the Development of Microalbuminuria | Biotech Hunter | Biotech Hunter